Health Economics, Health Outcomes, and Market Access are extremely important departments that are growing rapidly within the pharmaceutical and biotechnology sector.
In order to effectively put a product to market and remain competitive, the pharmaceutical and biotechnology drug discovery organisations must be able to demonstrate clinical and economic evidence to providers, healthcare decision-makers and payers. This is the function of the Health Economic and Health Outcomes departments.
Within these departments you will find people doing economic evaluations, observational studies, strategic planning, pricing, reimbursement assessments and submission preparation to pricing bodies, to name but a few.
The work done in these departments shapes how a drug is sold, for what price and in which markets.
Many pharmaceutical companies are growing their own Health Economics, Outcome and Market Access functions, however, there is also a growing number of consultancies specialising in these areas too that offer variety and a challenging environment.
HEOR professionals require not only attention to detail but also diplomacy, great communication skills and an ability to see the bigger picture…